Janux Therapeutics

JANUX THERAPEUTICS INC

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Janux Therapeutics Inc

Press Releases

Clear Street Launches Healthcare & Biotechnology Equity Research

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer

Janux Therapeutics to Host Virtual R&D Day on July 24, 2025

Janux Therapeutics Highlights Pipeline Progress and Best-in-Class Potential of Novel Bispecific Platform for Autoimmune Diseases at Virtual R&D Day

Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck

Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

CGEM

CRGX

DCTH

ELVN

ERAS

IMTX

IPSC

JANX

MLTX

NUVB

PTGX

YMAB

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celcuity

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dyne Therapeutics

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Immatics

MannKind

Nanobiotix

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Arcus Biosciences

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Spyre Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Zenas BioPharma

Zymeworks

Barclays

Truist Securities

Stifel

Guggenheim

Piper Sandler

Comments

Janux Therapeutics

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO